Coral Laboratories Ltd vs Lasa Supergenerics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Coral Laboratories Ltd is ₹ 387.15 as of 24 Mar 15:44 . The P/E Ratio of Coral Laboratories Ltd changed from 8.5 on March 2021 to 10.4 on March 2025 . This represents a CAGR of 4.12% over 5 yearsThe P/E Ratio of Lasa Supergenerics Ltd changed from 10.7 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Coral Laboratories Ltd changed from ₹ 115.04 crore on March 2021 to ₹ 250.4 crore on March 2025 . This represents a CAGR of 16.83% over 5 yearsThe Market Cap of Lasa Supergenerics Ltd changed from ₹ 243.63 crore on March 2021 to ₹ 84.42 crore on March 2025 . This represents a CAGR of -19.10% over 5 years The revenue of Coral Laboratories Ltd for the Dec '25 is ₹ 24.06 crore as compare to the Sep '25 revenue of ₹ 22.07 crore. This represent the growth of 9.02% The revenue of Lasa Supergenerics Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 revenue of ₹ 3.07 crore. This represent the decline of -27.69% The ebitda of Coral Laboratories Ltd for the Dec '25 is ₹ 4.38 crore as compare to the Sep '25 ebitda of ₹ 7.97 crore. This represent the decline of -45.04% The ebitda of Lasa Supergenerics Ltd for the Dec '25 is ₹ -0.73 crore as compare to the Sep '25 ebitda of ₹ -3.99 crore. This represent the decline of -81.7% The net profit of Coral Laboratories Ltd changed from ₹ 8.8 crore to ₹ 2.78 crore over 7 quarters. This represents a CAGR of -48.24% The net profit of Lasa Supergenerics Ltd changed from ₹ -2.73 crore to ₹ -2.55 crore over 7 quarters. This represents a CAGR of -3.82% The Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lasa Supergenerics Ltd changed from 4.46 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Coral Laboratories Ltd

Coral Laboratories Limited (CLL) was established in February, 1997.
It was promoted by Navin B Doshi of the DWD Group.
To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company came up with a public issue in March, 1994 by raising funds of Rs.2.5 Crore.
It setup an additional ultra-modern manufacturing unit at Daman and the said Unit started the commercial production during March 2004.
It started the commercial production at Dehradun Plant in September, 2006. Presently, Company is into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited was incorporated on March 11, 2016.
The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing.
The Company is a veterinary API manufacturing entity, which was acquired in April, 2012.
The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra.
It specialises in catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India.

FAQs for the comparison of Coral Laboratories Ltd and Lasa Supergenerics Ltd

Which company has a larger market capitalization, Coral Laboratories Ltd or Lasa Supergenerics Ltd?

Market cap of Coral Laboratories Ltd is 151 Cr while Market cap of Lasa Supergenerics Ltd is 39 Cr

What are the key factors driving the stock performance of Coral Laboratories Ltd and Lasa Supergenerics Ltd?

The stock performance of Coral Laboratories Ltd and Lasa Supergenerics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Coral Laboratories Ltd and Lasa Supergenerics Ltd?

As of May 3, 2026, the Coral Laboratories Ltd stock price is INR ₹424.95. On the other hand, Lasa Supergenerics Ltd stock price is INR ₹7.96.

How do dividend payouts of Coral Laboratories Ltd and Lasa Supergenerics Ltd compare?

To compare the dividend payouts of Coral Laboratories Ltd and Lasa Supergenerics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.